Correlation between body mass index and COVID-19 transmission risk

Rosa-Zamboni, Daniela de la; Ortega-Riosvelasco, Fernando; González-García, Nadia; Saldívar-Salazar, Sergio; Guerrero-Díaz, Ana Carmen

doi:10.1038/s41366-022-01215-y

Cited by 3 publications

(2 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…During COVID-19 period risk of morbidity and mortality of obesity persons have increased. It is found that obese persons are infected and spread COVID-19 than those who have normal BMI (Mohajan, 2020a(Mohajan, , 2021ade la Rosa-Zamboni, D. et al, 2022). About 75.8% COVID-19 infected persons have been identified as obese, which is higher than the normal COVID-19 infected population (Gürbüz, 2020;Mohajan, 2020bMohajan, , 2021bMohajan, , 2022.…”

Section: Obesity and Covid-19mentioning

confidence: 99%

Obesity and Its Related Diseases: A New Escalating Alarming in Global Health

Mohajan

2023

JIMR

View full text Add to dashboard Cite

At present rising of obesity becomes a principal public global health and economic concern. In 1997, the World Health Organization (WHO) has declared the obesity as global epidemic. About one-third of the world population is now suffering from overweight or obesity. It is estimated that some diseases, such as hypertension, cardiovascular diseases, Alzheimer disease, asthma, metabolic syndrome, liver steatosis, gallbladder disease, osteoarthritis, obstructive sleep apnea, certain types of cancer, hypercholesterolemia, metabolic syndrome, musculoskeletal disorders (joint and muscle pains), and type 2 diabetes are increased globally due to obesity. Obesity can affect nearly every organ system of human body and even may cause of total heart failure. On the other hand, obesity is incurring substantial costs for healthcare that are already affected the society. Obesity can be prevented, avoided, and cured. Prevention of obesity is the best policy, but proper treatment is necessary who are already affected with obesity. This article tries to discuss aspects of obesity, such as causes and prevention of obesity.

show abstract

Section: Obesity and Covid-19mentioning

confidence: 99%

Obesity and Its Related Diseases: A New Escalating Alarming in Global Health

Mohajan

2023

JIMR

View full text Add to dashboard Cite

show abstract

“…A study showed that increased body weight without correlation with height statistically significantly contributed to mortality, intubation and hospitalization particularly in patients younger than 65 years. In the U.S., another study of more than 900,000 patients hospitalized with COVID-19 found that 30% of overweight patients were 29,30 .…”

Section: Peripheral Location Was the Second Factormentioning

confidence: 99%

A Discriminant Analysis of the Factors Affecting Abnormalities in Chest Computed Tomographies of 608-Group Patients with COVID-19 Pneumonia

Fangmongkol,

Posai

2023

J Health Sci Med Res

View full text Add to dashboard Cite

Objective: To study factor correlation and classification affecting abnormalities in chest computed tomographies (CTs) of 608-group patients with coronavirus disease 2019 (COVID-19) pneumonia. Material and Methods: We retrospectively collected data of 608-group patients with COVID-19 pneumonia from medical records combined with data from chest CTs which were interpreted by a radiologist for CT abnormalities. The findings were analyzed by descriptive statistics, Fisher’s Exact Test and multiple discriminant analysis (MDA) by a stepwise method. Results: The majority of the 161 patients were female (55.9%), with an average age of 62.90 years (S.D. 16.68) and average weight of 63.07 kg (S.D. 16.18), non-smoking and non-alcohol drinking (71.4% and 61.5%, respectively) and with underlying respiratory diseases (28.6%). The important symptoms brought to a doctor were main symptoms including fever, chills, cough, nasal congestion, sore throat, difficult breathing, shortness of breath (74.5%). The average duration from onset of the symptoms to perform chest CTs was 11.18 days (S.D. 5.42). The abnormalities of CTs chest such as characteristics and locations were periphery (54.7%) with ground-glass opacity (44.7%). The CT severity score was level 2 (24.8%) from 5 levels. MDA revealed there were 5 factors affecting the abnormalities in the chest CTs of 608-group patients with COVID-19 pneumonia. CT severity score, peripheral location, body weight, age and location in the lower lungs. These factors accurately predicted abnormalities in chest CTs (60.2%). Conclusion: Abnormalities in chest CTs, and factor correlation and classification that affect abnormalities in chest CTs of 608-group patients with COVID-19 pneumonia will benefit the medical and multidisciplinary team in helping to determine treatment method, accurately prognosing severity and reducing mortality.

show abstract